PDGF-mediated protection of SH-SY5Y cells against Tat toxin involves regulation of extracellular glutamate and intracellular calcium

Toxicol Appl Pharmacol. 2009 Oct 15;240(2):286-91. doi: 10.1016/j.taap.2009.06.020. Epub 2009 Jul 2.

Abstract

The human immunodeficiency virus (HIV-1) protein Tat has been implicated in mediating neuronal apoptosis, one of the hallmark features of HIV-associated dementia (HAD). Mitigation of the toxic effects of Tat could thus be a potential mechanism for reducing HIV toxicity in the brain. In this study we demonstrated that Tat-induced neurotoxicity was abolished by NMDA antagonist-MK801, suggesting the role of glutamate in this process. Furthermore, we also found that pretreatment of SH-SY5Y cells with PDGF exerted protection against Tat toxicity by decreasing extracellular glutamate levels. We also demonstrated that extracellular calcium chelator EGTA was able to abolish PDGF-mediated neuroprotection, thereby underscoring the role of calcium signaling in PDGF-mediated neuroprotection. We also showed that Erk signaling pathway was critical for PDGF-mediated protection of cells. Additionally, blocking calcium entry with EGTA resulted in suppression of PDGF-induced Erk activation. These findings thus underscore the role of PDGF-mediated calcium signaling and Erk phosphorylation in the protection of cells against HIV Tat toxicity.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Apoptosis* / drug effects
  • Becaplermin
  • Calcium Signaling* / drug effects
  • Caspase 3 / metabolism
  • Cell Line, Tumor
  • Cell Survival
  • Chelating Agents / pharmacology
  • Cytoprotection
  • Dizocilpine Maleate / pharmacology
  • Egtazic Acid / pharmacology
  • Enzyme Activation
  • Excitatory Amino Acid Antagonists / pharmacology
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Glutamic Acid / metabolism*
  • HIV-1 / metabolism*
  • Humans
  • Neuroblastoma / metabolism
  • Neuroblastoma / pathology
  • Neurons / drug effects
  • Neurons / metabolism*
  • Neurons / pathology
  • Neuroprotective Agents / pharmacology
  • Phosphorylation
  • Platelet-Derived Growth Factor / metabolism*
  • Proto-Oncogene Proteins c-sis
  • Receptors, N-Methyl-D-Aspartate / antagonists & inhibitors
  • Receptors, N-Methyl-D-Aspartate / metabolism
  • Recombinant Proteins / metabolism
  • Time Factors
  • tat Gene Products, Human Immunodeficiency Virus / metabolism*

Substances

  • Chelating Agents
  • Excitatory Amino Acid Antagonists
  • Neuroprotective Agents
  • Platelet-Derived Growth Factor
  • Proto-Oncogene Proteins c-sis
  • Receptors, N-Methyl-D-Aspartate
  • Recombinant Proteins
  • tat Gene Products, Human Immunodeficiency Virus
  • Becaplermin
  • Glutamic Acid
  • Egtazic Acid
  • Dizocilpine Maleate
  • Extracellular Signal-Regulated MAP Kinases
  • CASP3 protein, human
  • Caspase 3